Blog
Sunday, October 20, 2019, 14:03
Treatment with pitolisant is associated with reductions in excessive daytime sleepiness (EDS) and cataplexy over a 1-year period in patients with narcolepsy, according to research presented at World Sleep 2019, held September 20 to 25, 2019, in Vancouver, Canada.
Click here to continue reading this article.
No comments yet.